Related references
Note: Only part of the references are listed.Interferon regulatory factor 3 deficiency leads to interleukin-17-mediated liver ischemia-reperfusion injury
Patrizia Loi et al.
HEPATOLOGY (2013)
Liver grafts from CD39-overexpressing rodents are protected from ischemia reperfusion injury due to reduced numbers of resident CD4+ T cells
Sandra Pommey et al.
HEPATOLOGY (2013)
TIMP-1 deficiency leads to lethal partial hepatic ischemia and reperfusion injury
Sergio Duarte et al.
HEPATOLOGY (2012)
MicroRNA-181a, -146a and -146b in spleen CD4+ T lymphocytes play proinflammatory roles in a murine model of asthma
Meng-Jie Feng et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2012)
Liver Ischemia and Reperfusion Injury: New Insights into Mechanisms of Innate-Adaptive Immune-Mediated Tissue Inflammation
Y. Zhai et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2011)
TRAIL/DR5 Plays a Critical Role in NK Cell-Mediated Negative Regulation of Dendritic Cell Cross-Priming of T Cells
Mitsuhiro Iyori et al.
JOURNAL OF IMMUNOLOGY (2011)
Innate or Adaptive Immunity? The Example of Natural Killer Cells
Eric Vivier et al.
SCIENCE (2011)
Deletion of CD39 on Natural Killer Cells Attenuates Hepatic Ischemia/Reperfusion Injury in Mice
Guido Beldi et al.
HEPATOLOGY (2010)
Lipopolysaccharide-induced expression of TRAIL promotes dendritic cell differentiation
Young S. Cho et al.
IMMUNOLOGY (2010)
Crosstalk between components of the innate immune system: promoting anti-microbial defenses and avoiding immunopathologies
Karine Crozat et al.
IMMUNOLOGICAL REVIEWS (2009)
Hepatocyte-specific NEMO deletion promotes NK/NKT cell- and TRAIL-dependent liver damage
Naiara Beraza et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2009)
Molecular mediators of liver ischemia and reperfusion injury: A brief review
Andrew J. Vardanian et al.
MOLECULAR MEDICINE (2008)
Natural killer cells: diversity in search of a niche
James P. Di Santo
NATURE IMMUNOLOGY (2008)
Type I, but not type II, interferon is critical in liver injury induced after ischemia and reperfusion
Yuan Zhai et al.
HEPATOLOGY (2008)
Therapeutic treatment with poly(ADP-ribose) polymerase inhibitors attenuates the severity of acute pancreatitis and associated liver and lung injury
R. Mota et al.
BRITISH JOURNAL OF PHARMACOLOGY (2007)
TRAIL limits excessive host immune responses in bacterial meningitis
Olaf Hoffmann et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Developmental pathways that generate natural-killer-cell diversity in mice and humans
Nicholas D. Huntington et al.
NATURE REVIEWS IMMUNOLOGY (2007)
Hypoxia/reoxygenation up-regulated the expression of death receptor 5 and enhanced apoptosis in human hepatocyte line
L. Cao et al.
TRANSPLANTATION PROCEEDINGS (2006)
tRAIL receptor-mediated JNK activation and Bim phosphorylation critically regulate Fas-mediated liver damage and lethality
Nadia Corazza et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
Inflammatory responses in a new mouse model of prolonged hepatic cold ischemia followed by arterialized orthotopic liver transplantation
XD Shen et al.
LIVER TRANSPLANTATION (2005)
TRAIL identifies immature natural killer cells in newborn mice and adult mouse liver
K Takeda et al.
BLOOD (2005)
Immediate cytotoxicity but not degranulation distinguishes effector and memory subsets of CD8+ T cells
P Wolint et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2004)
Neutrophil-derived TNF-related apoptosis-inducing ligand (TRAIL): A novel mechanism of antitumor effect by neutrophils
Y Koga et al.
CANCER RESEARCH (2004)
CD107a as a functional marker for the identification of natural killer cell activity
G Alter et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2004)
Liver NK cells expressing TRAIL are toxic against self hepatocytes in mice
M Ochi et al.
HEPATOLOGY (2004)
Involvement of TWEAK in interferon γ-stimulated monocyte cytotoxicity
M Nakayama et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2000)
Share Paper
